We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Pushback Prompts EMA to Ease Postmarket Monitoring, Reporting
Industry Pushback Prompts EMA to Ease Postmarket Monitoring, Reporting
July 10, 2013
New guidance proposed by the European Medicines Agency addresses industry concerns that the EU’s 2010 pharmacovigilance law requires overly burdensome postmarket monitoring and reporting.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor